Blackstone to sell its share in Emcure PharmaceuticalsIllustrative image – not actual.

US private equity firm, Blackstone, will sell its share of 13.01 per cent invested in Pune-based company, Emcure Pharmaceuticals, to Bain Capital for Rs 700 crore.

 

Blackstone had acquired this stake in the year 2006 for $49 million (approx Rs 230 crore), which was the first investment made by the private equity firm in India.

 

Blackstone, which has its stake through one of its Mauritius-based companies, is selling off its share at three times more than its original investment.

 

Earlier, US-based private equity firm had sold its stake in outsourcing firm, Intelenet Global Services, in 2011 to UK-based Serco Group in an all-cash deal of about Rs 2,861 crore, and made a similar return on investments.

← All latest storiesBack to top →